Jean-Luc Harousseau Award in recognition for achievements which have advanced the field of multiple myeloma, and established the milestones and foundations of modern myeloma therapy.

In more than 40 years of active career, Dr Harousseau has devoted his professional life to advance clinical research in multiple myeloma. He has gained recognition across the globe as a pioneer and leader in this field. This award acknowledges and celebrates important research achievements. Dr Harousseau’s dedication to myeloma, hard work, and excellence in clinical care, ultimately resulting in improvement in patient care, are among the many reasons for which this award was named in his honor.

Open call deadline: April 14, 2025

Jean-Luc Harousseau Award for achievements which have advanced the field of multiple myeloma, and established the milestones and foundations of modern myeloma therapy.

In more than 40 years of active career, Dr Harousseau has devoted his professional life to advance clinical research in multiple myeloma. He has gained recognition across the globe as a pioneer and leader in this field. This award acknowledges and celebrates important research achievements. Dr Harousseau’s dedication to myeloma, hard work, and excellence in clinical care, ultimately resulting in improvement in patient care, are among the many reasons for which this award was named in his honor.

Criteria for application:
Significant contribution to the field of interest of the award.

​Candidates must submit their detailed CV (maximum of 10 A4 pages, single-spaced, 12 font) A maximum of 25 articles can be presented per candidate.

Only original papers will be mainly evaluated (usually excluding reviews, editorials, and summaries of press releases at Congresses, speeches and retractions).

Only articles for which the candidate is the first or last author will be evaluated. Journal impact factor must be submitted along with the references, in order to allow for calculation of the cumulative impact factor of the candidate.

Deadline for application/ nomination of candidacy for this award is April 14th.

Please send all applications to: [email protected], noting in the subject line: COMy 2025 JLH Award

The COMy Congress Organizing Committee is honored to recognize outstanding individuals that are continuing to drive fundamental clinical and basic research forward, broadening tomorrow’s scientific and clinical horizons, with the objective of improving patient care in the field of multiple myeloma.

This award will be presented during the 2025 COMy Congress and the awardee will be invited to give a lecture during the Award Ceremony Session.

Sincerely,

On behalf of the COMy Congress Organizing Committee

Mohamad Mohty
María-Victoria Mateos
Arnon Nagler

COMy Congress Co-Chairs

Women in Multiple Myeloma Achievement Award honors outstanding women in the field who have made groundbreaking contributions to innovative research. This award recognizes those whose work has significantly advanced the understanding and treatment of Multiple Myeloma. By driving fundamental clinical and basic research, these trailblazers have expanded the scientific and clinical horizons, with a clear focus on improving patient care and shaping the future of our field.

Supported by

Open call deadline: April 14, 2025

The COMy Women in Multiple Myeloma Achievement Award honors outstanding women in the field who have made groundbreaking contributions to innovative research. This award recognizes those whose work has significantly advanced the understanding and treatment of Multiple Myeloma. By driving fundamental clinical and basic research, these trailblazers have expanded the scientific and clinical horizons, with a clear focus on improving patient care and shaping the future of our field.

Criteria for application:
Significant contribution to the field of interest of the award.

​Candidates must submit their detailed CV (maximum of 10 A4 pages, single-spaced, 12 font) A maximum of 25 articles can be presented per candidate.

Only original papers will be mainly evaluated (usually excluding reviews, editorials, and summaries of press releases at Congresses, speeches and retractions).

Only articles for which the candidate is the first or last author will be evaluated. Journal impact factor must be submitted along with the references, in order to allow for calculation of the cumulative impact factor of the candidate.

Deadline for application/ nomination of candidacy for this award is April 14th.

Please send all applications to: [email protected], noting in the subject line: COMy 2025 JLH Award

The COMy Congress Organizing Committee is honored to recognize outstanding individuals that are continuing to drive the field of multiple myeloma.

This award will be presented during the 2025 COMy Congress and the awardee will be invited to give a lecture during the Award Ceremony Session.

Sincerely,

On behalf of the COMy Congress Organizing Committee

Mohamad Mohty
María-Victoria Mateos
Arnon Nagler

COMy Congress Co-Chairs

Multiple Myeloma Pioneers Award recognizes retired physicians, researchers and/or scientists whose longstanding and outstanding contributions and efforts have helped to significantly advance myeloma management, and established the milestones and foundations of modern practice in this field.

Awardee to be determined by the COMy Scientific Committee